Skip to main content
Version: 3.9.x

Regulatory Coverage

P4SaMD assesses medical device software against the regulatory requirements of three markets: the European Union, the United States and the United Kingdom. Check what each market covers before you start an assessment.

Supported markets​

MarketCodeRegulatory basis
European UnionEUMDR (EU) 2017/745
United StatesUSFDA, under the Federal Food, Drug, and Cosmetic Act
United KingdomUKUKCA, UK MDR 2002

Choose one or more of these markets in the Target Definition step of the Brownfield Import wizard. The market, the regulatory framework and the software safety class together determine which requirements are checked.

Standards applied in every market​

These standards are assessed whichever market you select, because all three markets rely on them.

StandardScope
IEC 62304:2006/AMD1:2015Software life cycle processes
ISO 14971:2019/A11:2021Application of risk management to medical devices
IEC 62366-1:2015Application of usability engineering to medical devices
ISO 13485:2016Quality management system clauses that touch the software life cycle: software validation, documentation and records, design and development, purchasing, servicing and traceability, feedback and complaints, internal audit, nonconformity and corrective and preventive action
IEC 81001-5-1:2021Security activities in the health software life cycle: secure design and coding, security requirements, security testing, release, maintenance, security risk management and issue handling, and the transitional path for legacy software

European Union​

FrameworkScope
MDR (EU) 2017/745Device classification (including a proposed Rule 11 class compared with your declared class), technical documentation, clinical evaluation, post-market surveillance, UDI and registration
IVDR (EU) 2017/746General safety and performance requirements, technical documentation, manufacturer obligations, classification, conformity assessment, CE marking, UDI and EUDAMED, performance evaluation, post-market surveillance and vigilance, and the transitional provisions
GDPR (EU) 2016/679Lawful basis, data minimization, retention, right to erasure, data protection by design, DPIA and security measures
EU AI Act (EU) 2024/1689High-risk AI classification, risk management system, data governance, technical documentation, transparency and human oversight
NIS2 (EU) 2022/2555Security risk management, incident handling, business continuity and vulnerability management
MDCG 2019-16Cybersecurity guidance for medical devices

United States​

FrameworkScope
FD&C Act section 524BPremarket cybersecurity: security risk management, security architecture, cybersecurity testing and software bill of materials
FD&C Act section 502Labeling and postmarket obligations

United States coverage addresses cybersecurity and labeling obligations. It is not an assessment of 510(k) or PMA submission readiness.

United Kingdom​

The United Kingdom is available as a target market, assessed against the international standards listed above. The platform does not currently carry rule content specific to UK MDR 2002 or UKCA conformity assessment. If your submission depends on UK-specific requirements, contact us to have coverage scoped.

Support for individual EU member states​

The European Union is assessed at Union level, against the EU regulations listed above. National implementations of EU law differ between member states, for example in registration routes, language requirements and national annexes. P4SaMD does not assess member-state requirements as delivered.

Available on request

Coverage for a specific EU member state can be enabled for your organization. It requires new regulatory rule content, so it is scoped as part of your engagement with Mia-Care rather than switched on from the settings page. Contact us with the member states you need.

Markets outside this list​

No market other than the three above is assessed today. If you are placing a device in an unlisted market, contact us before you start an assessment to find out which of your evidence carries over.